Annual SG&A:
$288.93M+$138.34M(+91.87%)Summary
- As of today, BBIO annual SG&A is $288.93 million, with the most recent change of +$138.34 million (+91.87%) on December 31, 2024.
- During the last 3 years, BBIO annual SG&A has risen by +$96.72 million (+50.32%).
- BBIO annual SG&A is now at all-time high.
Performance
BBIO SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$129.15M+$22.79M(+21.43%)Summary
- As of today, BBIO quarterly SG&A is $129.15 million, with the most recent change of +$22.79 million (+21.43%) on June 30, 2025.
- Over the past year, BBIO quarterly SG&A has increased by +$69.63 million (+116.98%).
- BBIO quarterly SG&A is now at all-time high.
Performance
BBIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$12.64B-$776.41M(-6.55%)Summary
- As of today, BBIO TTM SG&A is -$12.64 billion, with the most recent change of -$776.41 million (-6.55%) on June 30, 2025.
- Over the past year, BBIO TTM SG&A has dropped by -$12.85 billion (-6155.27%).
- BBIO TTM SG&A is now -6942.17% below its all-time high of -$179.44 million.
Performance
BBIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
BBIO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +91.9% | +117.0% | -6155.3% |
| 3Y3 Years | +50.3% | +254.6% | -7082.7% |
| 5Y5 Years | +206.2% | +240.2% | -8923.4% |
BBIO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +101.8% | at high | +315.2% | -94.6% | at low |
| 5Y | 5-Year | at high | +206.2% | at high | +315.2% | -427.9% | at low |
| All-Time | All-Time | at high | +2072.1% | at high | +1513.0% | -6942.2% | at low |
BBIO Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $129.15M(+21.4%) | $399.12M(+21.1%) |
| Mar 2025 | - | $106.36M(+12.2%) | $329.49M(+14.0%) |
| Dec 2024 | $288.93M(+91.9%) | $94.78M(+37.7%) | $288.93M(+19.5%) |
| Sep 2024 | - | $68.82M(+15.6%) | $241.73M(+15.8%) |
| Jun 2024 | - | $59.52M(-9.5%) | $208.69M(+12.6%) |
| Mar 2024 | - | $65.81M(+38.3%) | $185.29M(+23.0%) |
| Dec 2023 | $150.59M(+5.2%) | $47.58M(+33.0%) | $150.59M(+11.7%) |
| Sep 2023 | - | $35.78M(-1.0%) | $134.87M(+3.5%) |
| Jun 2023 | - | $36.12M(+16.1%) | $130.28M(-0.2%) |
| Mar 2023 | - | $31.11M(-2.4%) | $130.58M(-8.8%) |
| Dec 2022 | $143.19M(-25.5%) | $31.86M(+2.2%) | $143.19M(-13.8%) |
| Sep 2022 | - | $31.19M(-14.4%) | $166.08M(-8.2%) |
| Jun 2022 | - | $36.43M(-16.7%) | $180.97M(-5.0%) |
| Mar 2022 | - | $43.71M(-20.2%) | $190.52M(-0.9%) |
| Dec 2021 | $192.21M | $54.75M(+18.8%) | $192.21M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $46.08M(+0.2%) | $174.90M(+6.1%) |
| Jun 2021 | - | $45.97M(+1.2%) | $164.83M(+5.1%) |
| Mar 2021 | - | $45.41M(+21.3%) | $156.83M(+7.7%) |
| Dec 2020 | $145.68M(+54.4%) | $37.44M(+3.9%) | $145.68M(+1.7%) |
| Sep 2020 | - | $36.02M(-5.1%) | $143.22M(+9.6%) |
| Jun 2020 | - | $37.97M(+10.8%) | $130.70M(+19.1%) |
| Mar 2020 | - | $34.26M(-2.0%) | $109.72M(+16.3%) |
| Dec 2019 | $94.35M(+116.5%) | $34.97M(+48.8%) | $94.35M(+27.9%) |
| Sep 2019 | - | $23.50M(+38.3%) | $73.76M(+21.8%) |
| Jun 2019 | - | $16.99M(-10.1%) | $60.58M(+11.2%) |
| Mar 2019 | - | $18.90M(+31.4%) | $54.48M(+25.0%) |
| Dec 2018 | $43.59M(+227.7%) | $14.38M(+39.5%) | $43.59M(+49.2%) |
| Sep 2018 | - | $10.31M(-5.4%) | $29.21M(+54.5%) |
| Jun 2018 | - | $10.89M(+36.0%) | $18.90M(+136.0%) |
| Mar 2018 | - | $8.01M | $8.01M |
| Dec 2017 | $13.30M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual SG&A?
- What is the all-time high annual SG&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual SG&A year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly SG&A year-on-year change?
- What is BridgeBio Pharma, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM SG&A year-on-year change?
What is BridgeBio Pharma, Inc. annual SG&A?
The current annual SG&A of BBIO is $288.93M
What is the all-time high annual SG&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual SG&A is $288.93M
What is BridgeBio Pharma, Inc. annual SG&A year-on-year change?
Over the past year, BBIO annual SG&A has changed by +$138.34M (+91.87%)
What is BridgeBio Pharma, Inc. quarterly SG&A?
The current quarterly SG&A of BBIO is $129.15M
What is the all-time high quarterly SG&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly SG&A is $129.15M
What is BridgeBio Pharma, Inc. quarterly SG&A year-on-year change?
Over the past year, BBIO quarterly SG&A has changed by +$69.63M (+116.98%)
What is BridgeBio Pharma, Inc. TTM SG&A?
The current TTM SG&A of BBIO is -$12.64B
What is the all-time high TTM SG&A for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM SG&A is -$179.44M
What is BridgeBio Pharma, Inc. TTM SG&A year-on-year change?
Over the past year, BBIO TTM SG&A has changed by -$12.85B (-6155.27%)